UCB Pharma GmbH
Schwarz Pharma AG:SCHWARZ PHARMA appoints new CFO
SCHWARZ PHARMA AG / Change of Personnel Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- SCHWARZ PHARMA appoints new CFO Olaf Elbracht appointed as new Chief Financial Officer of SCHWARZ PHARMA AG. The Supervisory Board of SCHWARZ PHARMA AG has appointed Olaf Elbracht as Executive Board member as of September 1, 2008. Within the Executive Board, Olaf Elbracht will serve as Chief Financial Officer (CFO), responsible for Finance, Controlling, Audit and IT. You find more information on the internet: www.schwarzpharma.com SCHWARZ PHARMA AG is listed in the General Standard of the Frankfurter Wertpapierbörse (Frankfurt stock exchange). Security code no. 722 190 / ISIN no.: DE 0007221905 SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Germany Corporate Communications: Sylva Heitzer, Tel: +49 2173 48 1238 Contact: Corporate Communications: Sylvia Heitzer, Tel: +49 2173 48 1238; 27.08.2008 Financial News transmitted by DGAP ---------------------------------------------------------------------- Language: English Issuer: SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Deutschland Phone: +49 2173 48 1866 Fax: +49 2173 48 1856 E-mail: antje.witte@schwarzpharma.com Internet: www.schwarzpharma.com ISIN: DE0007221905 WKN: 722190 Listed: Regulierter Markt in Frankfurt (General Standard), Düsseldorf; Freiverkehr in Berlin, Hannover, München, Hamburg, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden